# Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

> **NCT07268560** · — · RECRUITING · sponsor: **Sir Run Run Shaw Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Complicated Intra-Abdominal Infections, cIAIs
- Hospital-acquired Pneumonia (HAP)
- Ventilator-Associated Pneumonia (VAP)

## Interventions

- **DRUG:** Aztreonam-Avibactam

## Key facts

- **NCT ID:** NCT07268560
- **Lead sponsor:** Sir Run Run Shaw Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268560, "Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT07268560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*